SCHEMBL8970368

SCHEMBL8970368

O=CNC1CCc2ccc3ccccc3c2O1

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 18/20 0.52
NFKB2 Q00653 18/20 0.52
RELA Q04206 18/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10733681 0.78 NFKB1 (0.52) NFKB1NFKB2RELA
SCHEMBL633738 0.73 NFKB1 (0.56) NFKB1NFKB2RELA
SCHEMBL4902548 0.73 NFKB1 (0.52) NFKB1NFKB2RELA
SCHEMBL8048594 0.71 NFKB1 (0.72) NFKB1NFKB2RELA
SCHEMBL8044013 0.71 NFKB1 (0.68) NFKB1NFKB2RELA
SCHEMBL8045126 0.70 NFKB1 (0.62) NFKB1NFKB2RELA
SCHEMBL6749348 0.70 NFKB1 (0.62) NFKB1NFKB2RELA
Hydrochloric Acid SCHEMBL8970554 0.69 NFKB1 (0.61) NFKB1NFKB2RELA
SCHEMBL10510563 0.65 NFKB1 (0.59) NFKB1NFKB2RELA
SCHEMBL24102069 0.65 DPP4 (0.45) NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5585392-A TREATING OR PREVENTING STROKES BAYER AKTIENGESELLSCHAFT (DE) 1996-12-17 US disclosed
US-5506246-A Method for treating depression using substituted aminomethyltetralins and their heterocyclic analogues BAYER AKTIENGESELLSCHAFT (DE) 1996-04-09 US disclosed
EP-0352613-B1 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1994-04-20 EP disclosed
US-5300523-A Binding serotonin receptors, treating nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1994-04-05 US disclosed
US-5137901-A For binding 5-HT 1 receptors; treating central nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1992-08-11 US disclosed
EP-0352613-A2 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1990-01-31 EP disclosed